Screener
Processa Pharmaceuticals, Inc. PCSA Q2 2025 earnings
Reported August 7, 2025 · Before market open
EPS-$0.25Miss by $0.02
EPS estimate-$0.23
Next report
Oct 29, 2026 (in a month)EPS estimate-$1.00
Versus estimates
Diluted EPS
FAQ
- When did Processa Pharmaceuticals, Inc. report Q2 2025 earnings?
- Processa Pharmaceuticals, Inc. (PCSA) reported Q2 2025 earnings on August 7, 2025 before market open.
- What were Processa Pharmaceuticals, Inc.'s Q2 2025 revenue and EPS?
- Processa Pharmaceuticals, Inc. reported eps of $-0.25 for Q2 2025.
- Did Processa Pharmaceuticals, Inc. beat estimates in Q2 2025?
- EPS missed the consensus estimate of $-0.23 by $0.02.
- How did Processa Pharmaceuticals, Inc.'s Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 75.2% from $-1.01.
- Where can I find Processa Pharmaceuticals, Inc.'s Q2 2025 SEC filings?
- You can read the 8-K earnings release (0001493152-25-011680) and the 10-Q periodic report (0001493152-25-011685) directly on SEC EDGAR. The filing index links above go to sec.gov.
